TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 61 filers reported holding TELA BIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $36,270 | +268.5% | 7,717 | +344.5% | 0.00% | – |
| Q1 2024 | $9,843 | -16.4% | 1,736 | -2.4% | 0.00% | – |
| Q4 2023 | $11,777 | -32.4% | 1,779 | -18.3% | 0.00% | -100.0% |
| Q3 2023 | $17,416 | +384.2% | 2,177 | +513.2% | 0.00% | – |
| Q2 2023 | $3,597 | +71840.0% | 355 | -28.7% | 0.00% | – |
| Q1 2023 | $5 | -68.8% | 498 | -63.2% | 0.00% | -100.0% |
| Q4 2022 | $16 | -99.9% | 1,352 | -59.8% | 0.00% | – |
| Q3 2022 | $29,000 | -60.8% | 3,362 | -68.0% | 0.00% | -100.0% |
| Q2 2022 | $74,000 | +428.6% | 10,521 | +784.1% | 0.00% | – |
| Q1 2022 | $14,000 | +100.0% | 1,190 | +132.0% | 0.00% | – |
| Q4 2021 | $7,000 | -58.8% | 513 | -52.6% | 0.00% | – |
| Q2 2021 | $17,000 | +112.5% | 1,083 | +95.8% | 0.00% | – |
| Q1 2021 | $8,000 | -61.9% | 553 | -59.9% | 0.00% | -100.0% |
| Q4 2020 | $21,000 | -75.6% | 1,380 | -73.5% | 0.00% | 0.0% |
| Q3 2020 | $86,000 | +377.8% | 5,210 | +272.1% | 0.00% | 0.0% |
| Q2 2020 | $18,000 | -21.7% | 1,400 | -52.8% | 0.00% | 0.0% |
| Q1 2020 | $23,000 | – | 2,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,475,293 | $24,401,000 | 12.96% |
| Opaleye Management Inc. | 362,074 | $5,989,000 | 1.17% |
| COWEN AND COMPANY, LLC | 409,004 | $6,765,000 | 1.10% |
| SANDERS MORRIS HARRIS LLC | 163,121 | $2,698,000 | 0.73% |
| Millrace Asset Group, Inc. | 53,197 | $880,000 | 0.71% |
| Orbimed Advisors | 3,027,542 | $50,076,000 | 0.63% |
| RTW INVESTMENTS, LP | 1,378,776 | $22,805,000 | 0.55% |
| PURA VIDA INVESTMENTS, LLC | 288,605 | $4,774,000 | 0.25% |
| Alyeska Investment Group, L.P. | 461,197 | $7,628,000 | 0.12% |
| ARMISTICE CAPITAL, LLC | 160,000 | $2,646,000 | 0.10% |